UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis

Journal of inflammation research, 2022-10, Vol.15, p.5677-5685

2022

Volltextzugriff (PDF)

Clinical and microbiological monitoring of Cystic Fibrosis patients, three years of follow-up via Tele-Medicine: an empirical research

Clinica terapeutica, 2020-09, Vol.171 (5), p.e381-e384

2020

Volltextzugriff (PDF)

Age‐dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene

Neurogastroenterology and motility, 2009-06, Vol.21 (6), p.597-602

2009

Volltextzugriff (PDF)

Acoustic radiation force impulse (ARFI) imaging with Virtual Touch Tissue Quantification in liver disease associated with cystic fibrosis in children

Radiologia medica, 2012-12, Vol.117 (8), p.1408-1418

2012

Volltextzugriff (PDF)

Program of home telemonitoring in patients with cystic fibrosis over a period of 2 years: a contribution to the rationalization of care

Clinica terapeutica, 2013, Vol.164 (4), p.e313

2013

Volltextzugriff (PDF)

43 Atypical forms of cystic fibrosis (CF): The emerging diagnostic challenge for diagnosing CF in children and adolescents with a single-organ involvement

Journal of cystic fibrosis, 2011, Vol.10, p.S11-S11

2011

Volltextzugriff (PDF)

394 Cystic fibrosis liver disease: an emerging clinical issue showing a multifactorial pathogenesis

Journal of cystic fibrosis, 2011, Vol.10, p.S101-S101

2011

Volltextzugriff (PDF)

47 CFTR gene mutations and the risk for developing a pancreatic cancer: is it only a consequence of chronic inflammation?

Journal of cystic fibrosis, 2011, Vol.10, p.S12-S12

2011

Volltextzugriff (PDF)

WS13.2 Cystic fibrosis bone disease: is there a need for an earlier evaluation?

Journal of cystic fibrosis, 2012-06, Vol.11, p.S29-S29

2012

Volltextzugriff (PDF)

WS07.03 Better β-cell glucose sensitivity is associated with residual chloride conductance of the CFTR gene in people with cystic fibrosis

Journal of cystic fibrosis, 2024-06, Vol.23, p.S13-S13

2024

Volltextzugriff (PDF)

Is telemedicine useful in home management of cystic fibrosis patients?

Journal of cystic fibrosis, 2010, Vol.9, p.S61-S61

2010

Volltextzugriff (PDF)

P169 Psychometric properties of the gastrointestinal symptom tracker self-report measure

Journal of cystic fibrosis, 2022-06, Vol.21, p.S113

2022

Volltextzugriff (PDF)

Role of Aspergillus fumigatus colonization in the evolution of lung injury in CF patients

Journal of cystic fibrosis, 2010, Vol.9, p.S52-S52

2010

Volltextzugriff (PDF)

WS1.6 The need of an appropriate diagnosis of gastroesophageal reflux disease in cystic fibrosis patients: impact on clinical management

Journal of cystic fibrosis, 2012-06, Vol.11, p.S2-S2

2012

Volltextzugriff (PDF)

Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study

Journal of cystic fibrosis, 2022-03, Vol.21 (2), p.220-226

2022

Volltextzugriff (PDF)

390 Proof-of-concept of ionocyte cystic fibrosis transmembrane conductance regulator content as a novel biomarker for cystic fibrosis

Journal of cystic fibrosis, 2022-10, Vol.21, p.S228-S228

2022

Volltextzugriff (PDF)

P357 Effect of elexacaftor/tezacaftor/ivacaftor on metabolic parameters and body weight in patients with cystic fibrosis: a five case series with oneyear follow-up

Journal of cystic fibrosis, 2024-06, Vol.23, p.S177-S178

2024

Volltextzugriff (PDF)

P241 One month with elexacaftor/tezacaftor/ivacaftor in an Italian sample: quality of life and mental health

Journal of cystic fibrosis, 2022-06, Vol.21, p.S134

2022

Volltextzugriff (PDF)

P014 Proof of concept of ionocytes’ CFTR content as a novel biomarker for cystic fibrosis diagnosis and follow-up

Journal of cystic fibrosis, 2022-06, Vol.21, p.S64

2022

Volltextzugriff (PDF)

P094 Randomised controlled trial of humanoid robot-based distraction for invasive nursing procedures in children with cystic fibrosis: preliminary results

Journal of cystic fibrosis, 2022-06, Vol.21, p.S89

2022

Volltextzugriff (PDF)

P082 Is the new modulator affecting global health outcomes over time?

Journal of cystic fibrosis, 2023-06, Vol.22, p.S88-S88

2023

Volltextzugriff (PDF)

296 Positive longitudinal effects of elexacaftor/tezacaftor/ivacaftor across multiple domains of physical and mental health: Pre-post findings in an Italian sample

Journal of cystic fibrosis, 2022-10, Vol.21, p.S175-S176

2022

Volltextzugriff (PDF)

P379 Relationship between psychological symptoms, gastrointestinal symptoms, and Health-Related Quality of Life in cystic fibrosis (HRQoL)

Journal of cystic fibrosis, 2020-06, Vol.19, p.S162-S162

2020

Volltextzugriff (PDF)

WS06.03 Efficacy and safety of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) in people with cystic fibrosis and ELX/TEZ/IVA-responsive, non-F508del genotypes: a phase 3, randomised, placebo-controlled trial

Journal of cystic fibrosis, 2024-06, Vol.23, p.S11-S11

2024

Volltextzugriff (PDF)

Economic evaluation of telehomecare in chronic lung diseases

Clinica terapeutica, 2011, Vol.162 (2), p.e43

2011

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(100)
Tagungsberichte
(3)

Sprache

Englisch
(98)
Italienisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(31)
Humans
(29)
Female
(19)
Adult
(15)
Pulmonary/respiratory
(15)
Male
(13)
Middle Aged
(12)
Aged
(11)
Biological And Medical Sciences
(11)
Adolescent
(7)
Cystic Fibrosis
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Oncology
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Plant Sciences
(6)
Aged, 80 And Over
(5)
Breast Neoplasms - Drug Therapy
(5)
Fungal Plant Pathogens
(5)
Mutation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis

Clinical and microbiological monitoring of Cystic Fibrosis patients, three years of follow-up via Tele-Medicine: an empirical research

Age‐dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene

Acoustic radiation force impulse (ARFI) imaging with Virtual Touch Tissue Quantification in liver disease associated with cystic fibrosis in children

Program of home telemonitoring in patients with cystic fibrosis over a period of 2 years: a contribution to the rationalization of care

43 Atypical forms of cystic fibrosis (CF): The emerging diagnostic challenge for diagnosing CF in children and adolescents with a single-organ involvement

394 Cystic fibrosis liver disease: an emerging clinical issue showing a multifactorial pathogenesis

47 CFTR gene mutations and the risk for developing a pancreatic cancer: is it only a consequence of chronic inflammation?

WS13.2 Cystic fibrosis bone disease: is there a need for an earlier evaluation?

WS07.03 Better β-cell glucose sensitivity is associated with residual chloride conductance of the CFTR gene in people with cystic fibrosis

Is telemedicine useful in home management of cystic fibrosis patients?

P169 Psychometric properties of the gastrointestinal symptom tracker self-report measure

Role of Aspergillus fumigatus colonization in the evolution of lung injury in CF patients

WS1.6 The need of an appropriate diagnosis of gastroesophageal reflux disease in cystic fibrosis patients: impact on clinical management

Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study

390 Proof-of-concept of ionocyte cystic fibrosis transmembrane conductance regulator content as a novel biomarker for cystic fibrosis

P357 Effect of elexacaftor/tezacaftor/ivacaftor on metabolic parameters and body weight in patients with cystic fibrosis: a five case series with oneyear follow-up

P241 One month with elexacaftor/tezacaftor/ivacaftor in an Italian sample: quality of life and mental health

P014 Proof of concept of ionocytes’ CFTR content as a novel biomarker for cystic fibrosis diagnosis and follow-up

P094 Randomised controlled trial of humanoid robot-based distraction for invasive nursing procedures in children with cystic fibrosis: preliminary results

P082 Is the new modulator affecting global health outcomes over time?

296 Positive longitudinal effects of elexacaftor/tezacaftor/ivacaftor across multiple domains of physical and mental health: Pre-post findings in an Italian sample

P379 Relationship between psychological symptoms, gastrointestinal symptoms, and Health-Related Quality of Life in cystic fibrosis (HRQoL)

WS06.03 Efficacy and safety of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) in people with cystic fibrosis and ELX/TEZ/IVA-responsive, non-F508del genotypes: a phase 3, randomised, placebo-controlled trial

Economic evaluation of telehomecare in chronic lung diseases

Suchergebnisse filtern